Cancer/Tumor Profiling Market Share, Size, Trends, Industry Analysis Report by Technology (Immunoassay, NGS, PCR, In Situ Hybridization, Microarray, Mass Spectrometry, Others); By Biomarker Type (Genomic Biomarkers, Protein Biomarkers, Others); By Cancer Type; By Application; By Regions - Segment Forecast, 2020 - 2027

Table of Contents

1. Overview and Scope
   1. Research goal & scope
   2. 研究假设
   3. Research Methodology
      1. Primary data sources
      2. Secondary data sources
   4. Key take-aways
   5. Stakeholders
2. Executive Summary
   1. Market Definition
   2. Market Segmentation
3. Cancer/tumor Profiling Market Insights
   1. Cancer/tumor Profiling– Industry snapshot
   2. Cancer/tumor Profiling market dynamics
      1. Cancer/tumor Profiling– Market Forces
         1. Cancer/tumor Profiling Market driver analysis
         2. Cancer/tumor Profiling Market restraint/challenges analysis
         3. Cancer/tumor Profiling Market opportunity analysis
   3. Industry analysis - Porter's five force
      1. Bargaining power of supplier
      2. Bargaining power of buyer
      3. Threat of substitute
      4. Threat of new entrant
      5. 程度的竞争
   4. Cancer/tumor Profiling market PEST analysis
   5. Value Chain Analysis
   6. Competitive Ranking Analysis, 2019
4. Cancer/tumor Profiling Market Size and Forecast by Transducer Frequency Range
   1. Global Cancer/tumor Profiling market share by technology, 2019 & 2027
   2. Immunoassay
      1. Global Immunoassay market estimates and forecasts, 2016 - 2027 (USD Million)
      2. Global Immunoassay market estimates and forecasts, by region, 2016 - 2027 (USD Million)
   3. Next Generation Sequencing (NGS)
      1. Global NGS market estimates and forecasts, 2016 - 2027 (USD Million)
      2. Global NGS market estimates and forecasts, by region, 2016 - 2027 (USD Million)
   4. Polymerase Chain Reaction (PCR)
      1. Global PCR market estimates and forecasts, 2016 - 2027 (USD Million)
      2. Global PCR market estimates and forecasts, by region, 2016 - 2027 (USD Million)
   5. In Situ Hybridization
      1. Global In Situ Hybridization market estimates and forecasts, 2016 - 2027 (USD Million)
      2. Global In Situ Hybridization market estimates and forecasts, by region, 2016 - 2027 (USD Million)
   6. Microarray
      1. Global Microarray market estimates and forecasts, 2016 - 2027 (USD Million)
      2. Global Microarray market estimates and forecasts, by region, 2016 - 2027 (USD Million)
   7. Mass Spectrometry
      1. 全球市场质谱估计和前casts, 2016 - 2027 (USD Million)
      2. 全球市场质谱估计和前casts, by region, 2016 - 2027 (USD Million)
   8. Other Technology
      1. Global Other Technology market estimates and forecasts, 2016 - 2027 (USD Million)
      2. Global Other Technology market estimates and forecasts, by region, 2016 - 2027 (USD Million)
5. Cancer/tumor Profiling Market Size and Forecast by Cancer Type
   1. Global Cancer/tumor Profiling market share by cancer type, 2019 & 2027
   2. Breast Cancer
      1. Global breast cancer/tumor profiling market estimates and forecasts, 2016 - 2027 (USD Million)
      2. Global breast cancer/tumor profiling market estimates and forecasts, by region, 2016 - 2027 (USD Million)
   3. Lung Cancer
      1. Global lung cancer/tumor profiling market estimates and forecasts, 2016 - 2027 (USD Million)
      2. Global lung cancer/tumor profiling market estimates and forecasts, by region, 2016 - 2027 (USD Million)
   4. Colorectal Cancer
      1. Global colorectal cancer/tumor profiling market estimates and forecasts, 2016 - 2027 (USD Million)
      2. Global colorectal cancer/tumor profiling market estimates and forecasts, by region, 2016 - 2027 (USD Million)
   5. Prostate Cancer
      1. Global prostate cancer/tumor profiling market estimates and forecasts, 2016 - 2027 (USD Million)
      2. Global prostate cancer/tumor profiling market estimates and forecasts, by region, 2016 - 2027 (USD Million)
   6. Melanoma Cancer
      1. Global Melanoma cancer/tumor profiling market estimates and forecasts, 2016 - 2027 (USD Million)
      2. Global melanoma cancer/tumor profiling market estimates and forecasts, by region, 2016 - 2027 (USD Million)
   7. Other Cancer
      1. Global other cancer/tumor profiling market estimates and forecasts, 2016 - 2027 (USD Million)
      2. Global other cancer/tumor profiling market estimates and forecasts, by region, 2016 - 2027 (USD Million)
6. Cancer/tumor Profiling Market Size and Forecast by Biomarker Type
   1. Global Cancer/tumor Profiling market share by biomarker type, 2019 & 2027
   2. Genomic Biomarkers
      1. Global genomic biomarkers cancer/tumor profiling market estimates and forecasts, 2016 - 2027 (USD Million)
      2. Global genomic biomarkers cancer/tumor profiling market estimates and forecasts, by region, 2016 - 2027 (USD Million)
   3. Protein Biomarkers
      1. Global protein biomarkers cancer/tumor profiling market estimates and forecasts, 2016 - 2027 (USD Million)
      2. Global protein biomarkers cancer/tumor profiling market estimates and forecasts, by region, 2016 - 2027 (USD Million)
   4. Other Biomarkers
      1. Global other biomarkers cancer/tumor profiling market estimates and forecasts, 2016 - 2027 (USD Million)
      2. Global other biomarkers cancer/tumor profiling market estimates and forecasts, by region, 2016 - 2027 (USD Million)
7. Cancer/tumor Profiling Market Size and Forecast by Application
   1. Global Cancer/tumor Profiling market share by application, 2019 & 2027
   2. Diagnostics
      1. Global Cancer/tumor Profiling market from diagnostics estimates and forecasts, 2016 - 2027 (USD Million)
      2. Global Cancer/tumor Profiling from diagnostics market estimates and forecasts, by region, 2016 - 2027 (USD Million)
   3. Prognostics
      1. Global Cancer/tumor Profiling market from Prognostics estimates and forecasts, 2016 - 2027 (USD Million)
      2. Global hard Cancer/tumor Profiling from Prognostics market estimates and forecasts, by region, 2016 - 2027 (USD Million)
   4. Personalized Medicine
      1. Global Cancer/tumor Profiling market from Personalized Medicine estimates and forecasts, 2016 - 2027 (USD Million)
      2. Global hard Cancer/tumor Profiling from Personalized Medicine market estimates and forecasts, by region, 2016 - 2027 (USD Million)
   5. Biomarker Discovery
      1. Global Cancer/tumor Profiling market from Biomarker Discovery estimates and forecasts, 2016 - 2027 (USD Million)
      2. Global hard Cancer/tumor Profiling from Biomarker Discovery market estimates and forecasts, by region, 2016 - 2027 (USD Million)
   6. Research
      1. Global Cancer/tumor Profiling market from Research estimates and forecasts, 2016 - 2027 (USD Million)
      2. Global hard Cancer/tumor Profiling from Research market estimates and forecasts, by region, 2016 - 2027 (USD Million)
8. Cancer/tumor Profiling Market Size and Forecast by Region
   1. Global cancer/tumor profiling market share by region, 2019 & 2027
   2. North America
      1. North America cancer/tumor profiling market by technology (USD Million), 2016 - 2027
      2. North America cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
      3. North America cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027
      4. North America cancer/tumor profiling market by application (USD Million), 2016 - 2027
      5. U.S.
         1. U.S. cancer/tumor profiling market by technology (USD Million), 2016 - 2027
         2. U.S. cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
         3. U.S. cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027
         4. U.S. cancer/tumor profiling market by application (USD Million), 2016 - 2027
      6. Canada
         1. Canada cancer/tumor profiling market by technology (USD Million), 2016 - 2027
         2. Canada cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
         3. Canada cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027
         4. Canada cancer/tumor profiling market by application (USD Million), 2016 - 2027
   3. Europe
      1. Europe cancer/tumor profiling market by technology (USD Million), 2016 - 2027
      2. Europe cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
      3. 欧洲癌症和肿瘤生物标志物分析市场type (USD Million), 2016 - 2027
      4. Europe cancer/tumor profiling market by application (USD Million), 2016 - 2027
      5. 德国
         1. 德国cancer/tumor profiling market by technology (USD Million), 2016 - 2027
         2. 德国cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
         3. 德国cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027
         4. 德国cancer/tumor profiling market by application (USD Million), 2016 - 2027
      6. UK
         1. UK cancer/tumor profiling market by technology (USD Million), 2016 - 2027
         2. UK cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
         3. UK cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027
         4. UK cancer/tumor profiling market by application (USD Million), 2016 - 2027
      7. France
         1. France cancer/tumor profiling market by technology (USD Million), 2016 - 2027
         2. France cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
         3. France cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027
         4. France cancer/tumor profiling market by application (USD Million), 2016 - 2027
      8. Italy
         1. Ital cancer/tumor profiling market by technology (USD Million), 2016 - 2027
         2. Italy cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
         3. Italy cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027
         4. Italy cancer/tumor profiling market by application (USD Million), 2016 - 2027
      9. Spain
         1. 西班牙癌症肿瘤/ profiling market by technology (USD Million), 2016 - 2027
         2. 西班牙癌症肿瘤/ profiling market by cancer type (USD Million), 2016 - 2027
         3. 西班牙癌症肿瘤/ profiling market by biomarker type (USD Million), 2016 - 2027
         4. 西班牙癌症肿瘤/ profiling market by application (USD Million), 2016 – 2027
      10. Netherlands
          1. Netherlands cancer/tumor profiling market by technology (USD Million), 2016 - 2027
          2. Netherlands cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
          3. Netherlands cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027
          4. Netherlands cancer/tumor profiling market by application (USD Million), 2016 - 2027
   4. Asia Pacific
      1. Asia Pacific cancer/tumor profiling market by technology (USD Million), 2016 - 2027
      2. Asia Pacific cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
      3. Asia Pacific cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027
      4. Asia Pacific cancer/tumor profiling market by application (USD Million), 2016 - 2027
      5. China
         1. China cancer/tumor profiling market by technology (USD Million), 2016 - 2027
         2. China cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
         3. China cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027
         4. China cancer/tumor profiling market by application (USD Million), 2016 - 2027
      6. South Korea
         1. South Korea cancer/tumor profiling market by technology (USD Million), 2016 - 2027
         2. South Korea cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
         3. South Korea cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027
         4. South Korea cancer/tumor profiling market by application (USD Million), 2016 - 2027
      7. Japan
         1. Japan cancer/tumor profiling market by technology (USD Million), 2016 - 2027
         2. Japan cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
         3. Japan cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027
         4. Japan cancer/tumor profiling market by application (USD Million), 2016 - 2027
      8. India
         1. India cancer/tumor profiling market by technology (USD Million), 2016 - 2027
         2. India cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
         3. 印度癌症肿瘤生物标志物分析市场/ type (USD Million), 2016 - 2027
         4. India cancer/tumor profiling market by application (USD Million), 2016 - 2027
   5. Latin America
      1. Latin America cancer/tumor profiling market by technology (USD Million), 2016 - 2027
      2. Latin America cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
      3. Latin America cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027
      4. Latin America cancer/tumor profiling market by application (USD Million), 2016 - 2027
      5. Brazil
         1. Brazil cancer/tumor profiling market by technology (USD Million), 2016 - 2027
         2. Brazil cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
         3. Brazil cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027
         4. Brazil cancer/tumor profiling market by application (USD Million), 2016 - 2027
      6. Mexico
         1. Mexico cancer/tumor profiling market by technology (USD Million), 2016 - 2027
         2. Mexico cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
         3. Mexico cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027
         4. Mexico cancer/tumor profiling market by application (USD Million), 2016 - 2027
      7. Colombia
         1. Colombia cancer/tumor profiling market by technology (USD Million), 2016 - 2027
         2. Colombia cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
         3. Colombia cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027
         4. Colombia cancer/tumor profiling market by application (USD Million), 2016 - 2027
   6. Middle East & Africa
      1. MEA cancer/tumor profiling market by technology (USD Million), 2016 - 2027
      2. MEA cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
      3. MEA cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027
      4. MEA cancer/tumor profiling market by application (USD Million), 2016 - 2027
      5. Saudi Arabia
         1. Saudi Arabia cancer/tumor profiling market by technology (USD Million), 2016 - 2027
         2. Saudi Arabia cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
         3. Saudi Arabia cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027
         4. Saudi Arabia cancer/tumor profiling market by application (USD Million), 2016 - 2027
      6. South Africa
         1. South Africa cancer/tumor profiling market by technology (USD Million), 2016 - 2027
         2. South Africa cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
         3. South Africa cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027
         4. South Africa cancer/tumor profiling market by application (USD Million), 2016 - 2027
      7. Israel
         1. Israel cancer/tumor profiling market by technology (USD Million), 2016 - 2027
         2. Israel cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
         3. Israel cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027
         4. Israel cancer/tumor profiling market by application (USD Million), 2016 - 2027
      8. UAE
         1. UAE cancer/tumor profiling market by technology (USD Million), 2016 - 2027
         2. UAE cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
         3. UAE cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027
         4. UAE cancer/tumor profiling market by application (USD Million), 2016 - 2027
9. Company Profiles
   1. Abott Molecular
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   2. Agendia
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   3. Boreal Genomics Inc
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   4. BD Biosciences
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   5. Caris Life Sciences
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   6. F. Hoffmann-La Roche Ltd
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   7. Foundation Medicine
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   8. Genscript Biotech Corporation
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   9. Guardant Health, Inc.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   10. Helomics Corporation
       1. Overview
       2. Financials
       3. Product Benchmarking
       4. Recent Developments
   11. Histogene X
       1. Overview
       2. Financials
       3. Product Benchmarking
       4. Recent Developments
   12. Hologic, Inc.
       1. Overview
       2. Financials
       3. Product Benchmarking
       4. Recent Developments
   13. HTG Molecular Diagnostics, Inc.
       1. Overview
       2. Financials
       3. Product Benchmarking
       4. Recent Developments
   14. Illumina, Inc.
       1. Overview
       2. Financials
       3. Product Benchmarking
       4. Recent Developments
   15. Nanostring Technologies, Inc.
       1. Overview
       2. Financials
       3. Product Benchmarking
       4. Recent Developments
   16. Neogenomics, Inc.
       1. Overview
       2. Financials
       3. Product Benchmarking
       4. Recent Developments
   17. Omniseq
       1. Overview
       2. Financials
       3. Product Benchmarking
       4. Recent Developments
   18. Perthera
       1. Overview
       2. Financials
       3. Product Benchmarking
       4. Recent Developments
   19. Qiagen N.V.
       1. Overview
       2. Financials
       3. Product Benchmarking
       4. Recent Developments
   20. Ribomed Biotechnologies, Inc.
       1. Overview
       2. Financials
       3. Product Benchmarking
       4. Recent Developments
   21. Roche Molecular Systems Inc.
       1. Overview
       2. Financials
       3. Product Benchmarking
       4. Recent Developments
   22. Sysmex Corporation
       1. Overview
       2. Financials
       3. Product Benchmarking
       4. Recent Developments
   23. Tempus Labs
       1. Overview
       2. Financials
       3. Product Benchmarking
       4. Recent Developments

List of Tables

Table 1 Global cancer/tumor profiling market (USD Million) 2016 - 2027
Table 2 Global cancer/tumor profiling market by region 2016 - 2027 (USD Million)
Table 3 Global cancer/tumor profiling market by technology, 2016 - 2027 (USD Million)
Table 4 Global cancer/tumor profiling market by cancer type, 2016 - 2027 (USD Million)
Table 5 Global cancer/tumor profiling market by biomarker type, 2016 - 2027 (USD Million)
Table 6 Global cancer/tumor profiling market by application, 2016 - 2027 (USD Million)
Table 7 Immunoassay market, 2016 - 2027 (USD Million)
Table 8 Immunoassay market, by region, 2016 - 2027 (USD Million)
Table 9 NGS market, 2016 - 2027 (USD Million)
Table 10 NGS market, by region, 2016 - 2027 (USD Million)
Table 11 PCR market, 2016 - 2027 (USD Million)
Table 12 PCR market, by region, 2016 - 2027 (USD Million)
Table 13 In Situ Hybridization market, 2016 - 2027 (USD Million)
Table 14 In Situ Hybridization market, by region, 2016 - 2027 (USD Million)
Table 15 Microarray market estimates and forecasts, 2016 - 2027 (USD Million)
Table 16 Microarray market estimates and forecasts, by region, 2016 - 2027 (USD Million)
Table 17 Mass Spectrometry market estimates and forecasts, 2016 - 2027 (USD Million)
Table 18 Mass Spectrometry market estimates and forecasts, by region, 2016 - 2027 (USD Million)
Table 19 Other Technology market estimates and forecasts, 2016 - 2027 (USD Million)
Table 20 Other Technology market estimates and forecasts, by region, 2016 - 2027 (USD Million)
Table 21 breast cancer/tumor profiling market estimates and forecasts, 2016 - 2027 (USD Million)
Table 22 breast cancer/tumor profiling market estimates and forecasts, by region, 2016 - 2027 (USD Million)
Table 23 lung cancer/tumor profiling market estimates and forecasts, 2016 - 2027 (USD Million)
Table 24 colorectal cancer/tumor profiling market estimates and forecasts, 2016 - 2027 (USD Million)
Table 25 colorectal cancer/tumor profiling market estimates and forecasts, by region, 2016 - 2027 (USD Million)
Table 26 prostate cancer/tumor profiling market estimates and forecasts, 2016 - 2027 (USD Million)
Table 27 prostate cancer/tumor profiling market estimates and forecasts, by region, 2016 - 2027 (USD Million)
Table 28 Melanoma cancer/tumor profiling market estimates and forecasts, 2016 - 2027 (USD Million)
Table 29 melanoma cancer/tumor profiling market estimates and forecasts, by region, 2016 - 2027 (USD Million)
Table 30 other cancer/tumor profiling market estimates and forecasts, 2016 - 2027 (USD Million)
Table 31 other cancer/tumor profiling market estimates and forecasts, by region, 2016 - 2027 (USD Million)
Table 32 genomic biomarkers cancer/tumor profiling market estimates and forecasts, 2016 - 2027 (USD Million)
Table 33 genomic biomarkers cancer/tumor profiling market estimates and forecasts, by region, 2016 - 2027 (USD Million)
Table 34 protein biomarkers cancer/tumor profiling market estimates and forecasts, 2016 - 2027 (USD Million)
Table 35 protein biomarkers cancer/tumor profiling market estimates and forecasts, by region, 2016 - 2027 (USD Million)
Table 36 other biomarkers cancer/tumor profiling market estimates and forecasts, 2016 - 2027 (USD Million)
Table 37 other biomarkers cancer/tumor profiling market estimates and forecasts, by region, 2016 - 2027 (USD Million)
Table 38 Cancer/tumor Profiling market from diagnostics estimates and forecasts, 2016 - 2027 (USD Million)
Table 39 Cancer/tumor Profiling from diagnostics market estimates and forecasts, by region, 2016 - 2027 (USD Million)
Table 40 Cancer/tumor Profiling market from Prognostics estimates and forecasts, 2016 - 2027 (USD Million)
Table 41 Cancer/tumor Profiling from Prognostics market estimates and forecasts, by region, 2016 - 2027 (USD Million)
Table 42 Cancer/tumor Profiling market from Personalized Medicine estimates and forecasts, 2016 - 2027 (USD Million)
Table 43 Cancer/tumor Profiling from Personalized Medicine market estimates and forecasts, by region, 2016 - 2027 (USD Million)
Table 44 Cancer/tumor Profiling market from Biomarker Discovery estimates and forecasts, 2016 - 2027 (USD Million)
Table 45 Cancer/tumor Profiling from Biomarker Discovery market estimates and forecasts, by region, 2016 - 2027 (USD Million)
Table 46 Cancer/tumor Profiling market from Research estimates and forecasts, 2016 - 2027 (USD Million)
Table 47 Cancer/tumor Profiling from Research market estimates and forecasts, by region, 2016 - 2027 (USD Million)
Table 48 North America cancer/tumor profiling market by technology (USD Million), 2016 - 2027
Table 49 North America cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
Table 50 North America cancer/tumor profiling market by end user (USD Million), 2016 - 2027
Table 51 U.S. cancer/tumor profiling market by technology (USD Million), 2016 - 2027
Table 52 U.S. cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
Table 53 U.S. cancer/tumor profiling market by end user (USD Million), 2016 - 2027
Table 54 Canada cancer/tumor profiling market by technology (USD Million), 2016 - 2027
Table 55 Canada cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
Table 56 Canada cancer/tumor profiling market by end user (USD Million), 2016 - 2027
Table 57 Europe cancer/tumor profiling market by technology (USD Million), 2016 - 2027
Table 58 Europe cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
Table 59 Europe cancer/tumor profiling market by end user (USD Million), 2016 - 2027
Table 60 UK cancer/tumor profiling market by technology (USD Million), 2016 - 2027
Table 61 UK cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
Table 62 UK cancer/tumor profiling market by end user (USD Million), 2016 - 2027
Table 63 Germany cancer/tumor profiling market by technology (USD Million), 2016 - 2027
Table 64 Germany cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
Table 65 Germany cancer/tumor profiling market by end user (USD Million), 2016 - 2027
Table 66 France cancer/tumor profiling market by technology (USD Million), 2016 - 2027
Table 67 France cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
Table 68 France cancer/tumor profiling market by end user (USD Million), 2016 - 2027
Table 69 Italy cancer/tumor profiling market by technology (USD Million), 2016 - 2027
Table 70 Italy cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
Table 71 Italy cancer/tumor profiling market by end user (USD Million), 2016 - 2027
Table 72 Spain cancer/tumor profiling market by technology (USD Million), 2016 - 2027
Table 73 Spain cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
Table 74 Spain cancer/tumor profiling market by end user (USD Million), 2016 - 2027
Table 75 Netherlands cancer/tumor profiling market by technology (USD Million), 2016 - 2027
Table 76 Netherlands cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
Table 77 Netherlands cancer/tumor profiling market by end user (USD Million), 2016 - 2027
Table 78 Asia Pacific cancer/tumor profiling market by technology (USD Million), 2016 - 2027
Table 79 Asia Pacific cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
Table 80 Asia Pacific cancer/tumor profiling market by end user (USD Million), 2016 - 2027
Table 81 China cancer/tumor profiling market by technology (USD Million), 2016 - 2027
Table 82 China cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
Table 83 China cancer/tumor profiling market by end user (USD Million), 2016 - 2027
Table 84 India cancer/tumor profiling market by technology (USD Million), 2016 - 2027
Table 85 India cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
Table 86 India cancer/tumor profiling market by end user (USD Million), 2016 - 2027
Table 87 Japan cancer/tumor profiling market by technology (USD Million), 2016 - 2027
Table 88 Japan cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
Table 89 Japan cancer/tumor profiling market by end user (USD Million), 2016 - 2027
Table 90 South Korea cancer/tumor profiling market by technology (USD Million), 2016 - 2027
Table 91 South Korea cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
Table 92 South Korea cancer/tumor profiling market by end user (USD Million), 2016 - 2027
Table 93 Latin America cancer/tumor profiling market by technology (USD Million), 2016 - 2027
Table 94 Latin America cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
Table 95 Latin America cancer/tumor profiling market by end user (USD Million), 2016 - 2027
Table 96 Brazil cancer/tumor profiling market by technology (USD Million), 2016 - 2027
Table 97 Brazil cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
Table 98 Brazil cancer/tumor profiling market by end user (USD Million), 2016 - 2027
Table 99 Mexico cancer/tumor profiling market by technology (USD Million), 2016 - 2027
Table 100 Mexico cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
Table 101 Mexico cancer/tumor profiling market by end user (USD Million), 2016 - 2027
Table 102 Colombia cancer/tumor profiling market by technology (USD Million), 2016 - 2027
Table 103 Colombia cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
Table 104 Colombia cancer/tumor profiling market by end user (USD Million), 2016 - 2027
Table 105 MEA cancer/tumor profiling market by technology (USD Million), 2016 - 2027
Table 106 MEA cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
Table 107 MEA cancer/tumor profiling market by end user (USD Million), 2016 - 2027
Table 108 Saudi Arabia cancer/tumor profiling market by technology (USD Million), 2016 - 2027
Table 109 Saudi Arabia cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
Table 110 Saudi Arabia cancer/tumor profiling market by end user (USD Million), 2016 - 2027
Table 111 South Africa cancer/tumor profiling market by technology (USD Million), 2016 - 2027
Table 112 South Africa cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
Table 113 South Africa cancer/tumor profiling market by end user (USD Million), 2016 - 2027
Table 114 Israel cancer/tumor profiling market by technology (USD Million), 2016 - 2027
Table 115 Israel cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
Table 116 Israel cancer/tumor profiling market by end user (USD Million), 2016 - 2027
Table 117 UAE cancer/tumor profiling market by technology (USD Million), 2016 - 2027
Table 118 UAE cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027
Table 119 UAE cancer/tumor profiling market by end user (USD Million), 2016 - 2027

List of Figures

FIG 1. Market snapshot
FIG 2. Market segmentation & scope
FIG 3. Global Cancer/tumor Profiling market size and growth prospects, 2016 - 2027
FIG 4. Value chain analysis
FIG 5. Cancer/tumor Profiling market dynamics
FIG 6. Key market opportunities - prioritized
FIG 7. Industry analysis – Porter’s
FIG 8. PESTEL analysis
FIG 9. Global Cancer/tumor Profiling market share by technology, 2019 & 2027
FIG 10. Global Cancer/tumor Profiling market share by cancer type, 2019 & 2027
FIG 11. Global Cancer/tumor Profiling market share by biomarker type, 2019 & 2027
FIG 12. Global Cancer/tumor Profiling market share by application, 2019 & 2027
FIG 13. Global Cancer/tumor Profiling market share by region, 2019 & 2027
FIG 14. Competitive environment
FIG 15. Strategy framework